Alessandro Zuppardo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alessandro Zuppardo has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Carlo Viscomi
Veneto Institute of Molecular Medicine (VIMM), via Orus 2-35129 Padova, Italy
3 shared publications - Francesco Argenton
Department of Biology, University of Padova, Padova, Italy
2 shared publications - Giovanni Risato
Department of Biology, University of Padova, Padova, Italy
2 shared publications - Mara Doimo
Department of Women’s and Children’s Health, University of Padova, Padova, Italy
2 shared publications - Natascia Tiso
Department of Biology, University of Padova, Padova, Italy
2 shared publications - Nicola Facchinello
Department of Pharmacy and BioTechnology, University of Bologna, Bologna, Italy
2 shared publications
Latest Publications
- Open Access
- 31 August 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1) , 765
Correction: Model organisms in POLG-related disorders: insights from yeast to multicellular systems
- 31 August 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1) , 765
Open AccessCorrection: Model organisms in POLG-related disorders: insights from yeast to multicellular systems
- Open Access
- 26 December 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Model organisms in POLG-related disorders: insights from yeast to multicellular systems
Mitochondrial genetic diseases are complex disorders that impair cellular energy production, leading to diverse clinical manifestations across multiple organ systems. These diseases arise from mutations in either mitochondrial DNA or nuclear DNA. Among nuclear DNA-related cases, mutations in POLG and POLG2 , which encode subunits of mitochondrial DNA polymerase γ, are particularly significant, causing conditions such as Alpers–Huttenlocher syndrome and progressive external ophthalmoplegia. Model organisms have been instrumental in elucidating POLG-related disease mechanisms and advancing therapeutic strategies. Saccharomyces cerevisiae (budding yeast) provided insights into fundamental mitochondrial functions, while Caenorhabditis elegans (roundworm) helped explore POLG’s roles in multicellular organisms. Drosophila melanogaster (fruit fly) has been pivotal in studying neurological aspects, and Mus musculus (mouse) models contributed to understanding systemic effects in mammals. Recently, Danio rerio (zebrafish) has emerged as a promising vertebrate model for drug screening, due to its optical transparency and genetic tractability. Each model system offers unique advantages, collectively bridging the gap between basic research and clinical applications. This review will examine in vivo models used in POLG disorder research, highlighting their contributions to understanding disease mechanisms and therapeutic advancements.
- 26 December 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Open AccessModel organisms in POLG-related disorders: insights from yeast to multicellular systems
Mitochondrial genetic diseases are complex disorders that impair cellular energy production, leading to diverse clinical manifestations across multiple organ systems. These diseases arise from mutations in either mitochondrial DNA or nuclear DNA. Among nuclear DNA-related cases, mutations in POLG and POLG2 , which encode subunits of mitochondrial DNA polymerase γ, are particularly significant, causing conditions such as Alpers–Huttenlocher syndrome and progressive external ophthalmoplegia. Model organisms have been instrumental in elucidating POLG-related disease mechanisms and advancing therapeutic strategies. Saccharomyces cerevisiae (budding yeast) provided insights into fundamental mitochondrial functions, while Caenorhabditis elegans (roundworm) helped explore POLG’s roles in multicellular organisms. Drosophila melanogaster (fruit fly) has been pivotal in studying neurological aspects, and Mus musculus (mouse) models contributed to understanding systemic effects in mammals. Recently, Danio rerio (zebrafish) has emerged as a promising vertebrate model for drug screening, due to its optical transparency and genetic tractability. Each model system offers unique advantages, collectively bridging the gap between basic research and clinical applications. This review will examine in vivo models used in POLG disorder research, highlighting their contributions to understanding disease mechanisms and therapeutic advancements.
- Open Access
- 23 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 4782
Modelling POLG mutations in mice unravels a critical role of POLγΒ in regulating phenotypic severity
DNA polymerase γ (POLγ), responsible for mitochondrial DNA replication, consists of a catalytic POLγA subunit and two accessory POLγB subunits. Mutations in POLG, which encodes POLγA, lead to various mitochondrial diseases. We investigated the most common POLG mutations (A467T, W748S, G848S, Y955C) by characterizing human and mouse POLγ variants. Our data reveal that these mutations significantly impair POLγ activities, with mouse variants exhibiting milder defects. Cryogenic electron microscopy highlighted structural differences between human and mouse POLγ, particularly in the POLγB subunit, which may explain the higher activity of mouse POLγ and the reduced severity of mutations in mice. We further generated a panel of mouse models mirroring common human POLG mutations, providing crucial insights into the pathogenesis of POLG-related disorders and establishing robust models for therapeutic development. Our findings emphasize the importance of POLγB in modulating the severity of POLG mutations.
- 23 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 4782
Open AccessModelling POLG mutations in mice unravels a critical role of POLγΒ in regulating phenotypic severity
DNA polymerase γ (POLγ), responsible for mitochondrial DNA replication, consists of a catalytic POLγA subunit and two accessory POLγB subunits. Mutations in POLG, which encodes POLγA, lead to various mitochondrial diseases. We investigated the most common POLG mutations (A467T, W748S, G848S, Y955C) by characterizing human and mouse POLγ variants. Our data reveal that these mutations significantly impair POLγ activities, with mouse variants exhibiting milder defects. Cryogenic electron microscopy highlighted structural differences between human and mouse POLγ, particularly in the POLγB subunit, which may explain the higher activity of mouse POLγ and the reduced severity of mutations in mice. We further generated a panel of mouse models mirroring common human POLG mutations, providing crucial insights into the pathogenesis of POLG-related disorders and establishing robust models for therapeutic development. Our findings emphasize the importance of POLγB in modulating the severity of POLG mutations.